ClinicalTrials.govpublic full text
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
systemic lupus erythematosus, belimumab, pediatric, pharmacokinetics, pharmacodynamics, safety, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980279
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.